Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	HLA-E specific inhibitory MHC class Ib receptor activity	KLRC2 KLRD1	2.97e-05	4	45	2	GO:0062082
GeneOntologyMolecularFunction	inhibitory MHC class Ib receptor activity	KLRC2 KLRD1	2.97e-05	4	45	2	GO:0062080
GeneOntologyMolecularFunction	MHC class I protein complex binding	KLRC2 KLRD1	1.38e-04	8	45	2	GO:0023024
GeneOntologyMolecularFunction	protein antigen binding	KLRC2 KLRD1	5.84e-04	16	45	2	GO:1990405
GeneOntologyMolecularFunction	MHC class Ib receptor activity	KLRC2 KLRD1	8.29e-04	19	45	2	GO:0032394
GeneOntologyBiologicalProcess	stimulatory C-type lectin receptor signaling pathway	KLRC2 KLRC3 KLRD1	1.56e-05	23	44	3	GO:0002223
GeneOntologyBiologicalProcess	cellular response to lectin	KLRC2 KLRC3 KLRD1	1.56e-05	23	44	3	GO:1990858
GeneOntologyBiologicalProcess	response to lectin	KLRC2 KLRC3 KLRD1	1.56e-05	23	44	3	GO:1990840
GeneOntologyBiologicalProcess	positive regulation of natural killer cell mediated cytotoxicity	KLRC2 KLRC3 KLRD1	8.47e-05	40	44	3	GO:0045954
GeneOntologyBiologicalProcess	positive regulation of natural killer cell mediated immunity	KLRC2 KLRC3 KLRD1	1.13e-04	44	44	3	GO:0002717
GeneOntologyBiologicalProcess	regulation of lymphocyte mediated immunity	C4BPA KLRC2 KLRC3 KLRD1 SMAD7	1.31e-04	232	44	5	GO:0002706
Domain	-	TDRD6 RNF17	8.46e-05	6	45	2	2.40.50.90
Domain	Staphylococal_nuclease_OB-fold	TDRD6 RNF17	8.46e-05	6	45	2	IPR016071
Domain	TUDOR	TDRD6 RNF17	5.07e-04	14	45	2	PF00567
Domain	SMAD_dom-like	IRF6 SMAD7	6.67e-04	16	45	2	IPR017855
Domain	-	IRF6 SMAD7	6.67e-04	16	45	2	2.60.200.10
Domain	C_TYPE_LECTIN_1	KLRC2 KLRC3 KLRD1	9.43e-04	80	45	3	PS00615
Domain	Lectin_C	KLRC2 KLRC3 KLRD1	1.09e-03	84	45	3	PF00059
Domain	CLECT	KLRC2 KLRC3 KLRD1	1.09e-03	84	45	3	SM00034
Domain	C_TYPE_LECTIN_2	KLRC2 KLRC3 KLRD1	1.12e-03	85	45	3	PS50041
Domain	C-type_lectin-like	KLRC2 KLRC3 KLRD1	1.16e-03	86	45	3	IPR001304
Domain	TUDOR	TDRD6 RNF17	1.39e-03	23	45	2	PS50304
Domain	-	KLRC2 KLRC3 KLRD1	1.65e-03	97	45	3	3.10.100.10
Domain	C-type_lectin-like/link	KLRC2 KLRC3 KLRD1	1.74e-03	99	45	3	IPR016186
Domain	TUDOR	TDRD6 RNF17	1.92e-03	27	45	2	SM00333
Domain	-	CCIN KLHL26	1.92e-03	27	45	2	2.130.10.80
Domain	hEGF	FAT4 DLL1	2.06e-03	28	45	2	PF12661
Domain	CTDL_fold	KLRC2 KLRC3 KLRD1	2.18e-03	107	45	3	IPR016187
Domain	Tudor	TDRD6 RNF17	2.37e-03	30	45	2	IPR002999
Domain	Gal_Oxidase_b-propeller	CCIN KLHL26	3.03e-03	34	45	2	IPR015916
Domain	BTB	GMCL2 CCIN KLHL26	3.86e-03	131	45	3	PF00651
Domain	BTB	GMCL2 CCIN KLHL26	6.73e-03	160	45	3	PS50097
Domain	SMAD_FHA_domain	IRF6 SMAD7	6.97e-03	52	45	2	IPR008984
Domain	Kelch	CCIN KLHL26	8.61e-03	58	45	2	SM00612
Domain	Gal_Oxase/kelch_b-propeller	CCIN KLHL26	8.90e-03	59	45	2	IPR011043
Domain	BACK	CCIN KLHL26	9.19e-03	60	45	2	SM00875
Domain	BTB	GMCL2 CCIN KLHL26	9.28e-03	180	45	3	SM00225
Domain	BACK	CCIN KLHL26	9.49e-03	61	45	2	PF07707
Domain	BACK	CCIN KLHL26	9.49e-03	61	45	2	IPR011705
Domain	BTB/POZ_dom	GMCL2 CCIN KLHL26	1.00e-02	185	45	3	IPR000210
Domain	USP_CS	USP9Y USP47	1.10e-02	66	45	2	IPR018200
Domain	Kelch_1	CCIN KLHL26	1.24e-02	70	45	2	PF01344
Domain	Kelch_1	CCIN KLHL26	1.24e-02	70	45	2	IPR006652
Domain	USP_1	USP9Y USP47	1.24e-02	70	45	2	PS00972
Domain	UCH	USP9Y USP47	1.27e-02	71	45	2	PF00443
Domain	USP_2	USP9Y USP47	1.27e-02	71	45	2	PS00973
Domain	USP_3	USP9Y USP47	1.30e-02	72	45	2	PS50235
Domain	USP_dom	USP9Y USP47	1.30e-02	72	45	2	IPR028889
Domain	Peptidase_C19_UCH	USP9Y USP47	1.30e-02	72	45	2	IPR001394
Pathway	BIOCARTA_NKCELLS_PATHWAY	KLRC2 KLRC3 KLRD1	9.68e-06	20	30	3	M16355
Pathway	BIOCARTA_NKCELLS_PATHWAY	KLRC2 KLRC3 KLRD1	1.94e-05	25	30	3	MM1465
Pathway	REACTOME_DAP12_SIGNALING	KLRC2 KLRC3 KLRD1	3.76e-05	31	30	3	MM14886
Pathway	REACTOME_DAP12_INTERACTIONS	KLRC2 KLRC3 KLRD1	2.00e-04	54	30	3	MM14871
Pubmed	Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits.	KLRC2 KLRC3 KLRD1	8.09e-09	4	45	3	8943374
Pubmed	Development and function of CD94-deficient natural killer cells.	KLRC2 KLRC3 KLRD1	2.02e-08	5	45	3	21151939
Pubmed	Structural basis for NKG2A/CD94 recognition of HLA-E.	KLRC2 KLRC3 KLRD1	4.04e-08	6	45	3	18448674
Pubmed	Conservation and variation in human and common chimpanzee CD94 and NKG2 genes.	KLRC2 KLRC3 KLRD1	4.04e-08	6	45	3	11751968
Pubmed	Sequence analysis of a 62-kb region overlapping the human KLRC cluster of genes.	KLRC2 KLRC3 KLRD1	7.06e-08	7	45	3	9598306
Pubmed	Viral infection modulates Qa-1b in infected and bystander cells to properly direct NK cell killing.	KLRC2 KLRC3 KLRD1	1.13e-07	8	45	3	33765134
Pubmed	Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells.	KLRC2 KLRC3 KLRD1	1.13e-07	8	45	3	10601355
Pubmed	Bone marrow allograft rejection mediated by a novel murine NK receptor, NKG2I.	KLRC2 KLRC3 KLRD1	1.69e-07	9	45	3	14707119
Pubmed	Characterization of large-scale genomic differences in the first complete human genome.	KLRC2 KLRC3	1.64e-06	2	45	2	37403156
Pubmed	Reduced expansion of CD94/NKG2C+ NK cells in chronic lymphocytic leukemia and CLL-like monoclonal B-cell lymphocytosis is not related to increased human cytomegalovirus seronegativity or NKG2C deletions.	KLRC2 KLRD1	1.64e-06	2	45	2	33615729
Pubmed	NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus.	KLRC2 KLRD1	1.64e-06	2	45	2	24030638
Pubmed	The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.	KLRC2 KLRD1	1.64e-06	2	45	2	15940674
Pubmed	CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.	KLRC2 KLRD1	1.64e-06	2	45	2	20132973
Pubmed	Low gene expression levels of activating receptors of natural killer cells (NKG2E and CD94) in patients with fulminant type 1 diabetes.	KLRC3 KLRD1	1.64e-06	2	45	2	24177169
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	MYCBP2 TRRAP SEC23A USP47	2.93e-06	76	45	4	27542412
Pubmed	NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain.	KLRC2 KLRD1	4.91e-06	3	45	2	32575403
Pubmed	Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer.	KLRC3 KLRD1	4.91e-06	3	45	2	10201920
Pubmed	Human NKG2E is expressed and forms an intracytoplasmic complex with CD94 and DAP12.	KLRC3 KLRD1	4.91e-06	3	45	2	24935923
Pubmed	Variations of human killer cell lectin-like receptors: common occurrence of NKG2-C deletion in the general population.	KLRC2 KLRD1	4.91e-06	3	45	2	12618865
Pubmed	Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.	KLRC2 KLRD1	4.91e-06	3	45	2	10320637
Pubmed	Evidence of functional Cd94 polymorphism in a free-living house mouse population.	KLRC2 KLRD1	9.81e-06	4	45	2	30535636
Pubmed	Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation.	KLRC2 KLRD1	9.81e-06	4	45	2	11782535
Pubmed	Association of DAP12 with activating CD94/NKG2C NK cell receptors.	KLRC2 KLRD1	9.81e-06	4	45	2	9655483
Pubmed	CD94/NKG2A expression is associated with proliferative potential of CD8 T cells during persistent polyoma virus infection.	KLRC2 KLRD1	9.81e-06	4	45	2	16670321
Pubmed	The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition.	KLRC2 KLRD1	9.81e-06	4	45	2	18083576
Pubmed	Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.	KLRC2 KLRD1	9.81e-06	4	45	2	17767552
Pubmed	The human CD94 gene encodes multiple, expressible transcripts including a new partner of NKG2A/B.	KLRC2 KLRD1	9.81e-06	4	45	2	16237464
Pubmed	The CD94/NKG2A inhibitory receptor educates uterine NK cells to optimize pregnancy outcomes in humans and mice.	KLRC2 KLRD1	9.81e-06	4	45	2	33887202
Pubmed	HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.	KLRC2 KLRD1	9.81e-06	4	45	2	9486650
Pubmed	Rat and mouse CD94 associate directly with the activating transmembrane adaptor proteins DAP12 and DAP10 and activate NK cell cytotoxicity.	KLRC2 KLRD1	9.81e-06	4	45	2	22084441
Pubmed	Ly49 and CD94/NKG2 receptor acquisition by NK cells does not require lymphotoxin-beta receptor expression.	KLRC2 KLRD1	1.63e-05	5	45	2	15827137
Pubmed	Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b).	KLRC2 KLRD1	1.63e-05	5	45	2	9815261
Pubmed	IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2.	KLRC2 KLRD1	1.63e-05	5	45	2	15746081
Pubmed	HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.	KLRC2 KLRD1	1.63e-05	5	45	2	9754572
Pubmed	The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex.	KLRC2 KLRC3	1.63e-05	5	45	2	9683661
Pubmed	RNF17, a component of the mammalian germ cell nuage, is essential for spermiogenesis.	TDRD6 RNF17	1.63e-05	5	45	2	16093322
Pubmed	Human KLRF1, a novel member of the killer cell lectin-like receptor gene family: molecular characterization, genomic structure, physical mapping to the NK gene complex and expression analysis.	KLRC2 KLRD1	1.63e-05	5	45	2	10671213
Pubmed	Calcineurin-dependent negative regulation of CD94/NKG2A expression on naive CD8+ T cells.	KLRC2 KLRD1	1.63e-05	5	45	2	21540458
Pubmed	The balance between acetylation and deacetylation controls Smad7 stability.	HDAC6 SMAD7	2.45e-05	6	45	2	15831498
Pubmed	Cutting edge: engagement of NKG2A on CD8+ effector T cells limits immunopathology in influenza pneumonia.	KLRC2 KLRD1	3.42e-05	7	45	2	18096998
Pubmed	Qa-1(b)-dependent modulation of dendritic cell and NK cell cross-talk in vivo.	KLRC2 KLRD1	3.42e-05	7	45	2	17878358
Pubmed	Restricted expression of C-type lectin-like natural killer receptors by CD8 T cells in the murine small intestine.	KLRC2 KLRD1	3.42e-05	7	45	2	18298548
Pubmed	A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1b.	KLRC2 KLRD1	7.32e-05	10	45	2	22131332
Pubmed	Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma.	FAT4 TRRAP	8.94e-05	11	45	2	24349473
Pubmed	Identification and comparative analysis of hepatitis C virus-host cell protein interactions.	RLF MYCBP2	8.94e-05	11	45	2	24136289
Pubmed	Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1.	DLL1 SEC23A	8.94e-05	11	45	2	10196361
Pubmed	Epithelial-stromal interaction via Notch signaling is essential for the full maturation of gut-associated lymphoid tissues.	DLL1 MUC2	1.07e-04	12	45	2	25378482
Pubmed	Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.	HDAC6 SMAD7	1.94e-04	16	45	2	15831516
Pubmed	Tdrd6 is required for spermiogenesis, chromatoid body architecture, and regulation of miRNA expression.	TDRD6 RNF17	2.20e-04	17	45	2	19345099
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RLF LANCL1 HDAC6 MYCBP2 TRRAP EML4 ARMCX1 SEC23A	3.07e-04	1353	45	8	29467282
Pubmed	Co-adaptor driven assembly of a CUL3 E3 ligase complex.	SEC23A KLHL26	3.72e-04	22	45	2	35120648
Pubmed	Aberrant epidermal differentiation and disrupted ΔNp63/Notch regulatory axis in Ets1 transgenic mice.	IRF6 DLL1	4.07e-04	23	45	2	24337118
Pubmed	The ets-domain transcription factor Spdef promotes maturation of goblet and paneth cells in the intestinal epithelium.	DLL1 MUC2	4.07e-04	23	45	2	19549527
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	LANCL1 HDAC6 USP9Y LUC7L3 MYCBP2 TRRAP UNC13A	4.47e-04	1082	45	7	38697112
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	HDAC6 MYCBP2 TRRAP EML4 REXO1 USP47	4.63e-04	774	45	6	15302935
Pubmed	Tagging genes with cassette-exchange sites.	COX20 LUC7L3 RNF17 REXO1	9.23e-04	335	45	4	15741177
Pubmed	GATA4 and GATA6 regulate intestinal epithelial cytodifferentiation during development.	DLL1 MUC2	1.18e-03	39	45	2	24929016
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	HDAC6 DLL1 RNF17 MYCBP2	1.18e-03	358	45	4	32460013
Cytoband	12p13	KLRC2 KLRC3 KLRD1	3.52e-05	64	45	3	12p13
Cytoband	19p13.11	UNC13A KLHL26	2.36e-03	73	45	2	19p13.11
Cytoband	Ensembl 112 genes in cytogenetic band chr12p13	KLRC2 KLRC3 KLRD1	5.04e-03	353	45	3	chr12p13
Cytoband	1q44	COX20 OR2AK2	5.27e-03	110	45	2	1q44
Cytoband	Ensembl 112 genes in cytogenetic band chr1q44	COX20 OR2AK2	7.06e-03	128	45	2	chr1q44
GeneFamily	CD molecules\|C-type lectin domain family\|Killer cell lectin like receptors	KLRC2 KLRC3 KLRD1	1.10e-06	12	32	3	621
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	KLRC2 KLRC3 KLRD1	5.13e-05	41	32	3	1298
GeneFamily	Tudor domain containing	TDRD6 RNF17	1.94e-03	37	32	2	780
GeneFamily	Ubiquitin specific peptidases	USP9Y USP47	4.40e-03	56	32	2	366
Coexpression	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN	DPT NEB USP9Y	1.67e-05	29	45	3	M5126
Coexpression	GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP	VEGFC ADAMTS19 FAT4 KCNQ4 KLHL26	2.29e-05	199	45	5	M7420
Coexpression	TRAVAGLINI_LUNG_NATURAL_KILLER_T_CELL	KLRC2 KLRC3 KLRD1	2.73e-05	34	45	3	M41685
CoexpressionAtlas	NK cells, NK.DAP10-.Sp, NK1.1+ TCRb-, Spleen, avg-3	KLRC2 KLRC3 KLRD1	3.75e-04	71	42	3	GSM538294_100
CoexpressionAtlas	NK cells, NK.49CI-.Sp, NK1.1+ CD3- Ly49C/I-, Spleen, avg-3	KLRC2 KLRC3 KLRD1	3.75e-04	71	42	3	GSM538288_100
CoexpressionAtlas	NK cells, NK.49CI+.Sp, NK1.1+ CD3- Ly49C/I+, Spleen, avg-3	KLRC2 KLRC3 KLRD1	3.75e-04	71	42	3	GSM538285_100
CoexpressionAtlas	NK cells, NK.MCMV7.Sp, CD3-,NK1.1+, Spleen, avg-3	KLRC2 KLRC3 KLRD1	3.90e-04	72	42	3	GSM538312_100
CoexpressionAtlas	NK cells, NK.49H+.Sp, NK1.1+ Ly49H+, Spleen, avg-3	KLRC2 KLRC3 KLRD1	3.90e-04	72	42	3	GSM605814_100
CoexpressionAtlas	NK cells, NK.MCMV1.Sp, CD3-,NK1.1+, Spleen, avg-3	KLRC2 KLRC3 KLRD1	4.06e-04	73	42	3	GSM538309_100
CoexpressionAtlas	alpha beta T cells, T.8Mem.Sp.OT1.d100.LisOva, CD8+ CD45.1+, Spleen, avg-3	KLRC2 KLRC3 KLRD1	4.06e-04	73	42	3	GSM605904_100
CoexpressionAtlas	NK cells, NK.Sp, NK1.1+, Spleen, avg-3	KLRC2 KLRC3 KLRD1	4.06e-04	73	42	3	GSM538315_100
CoexpressionAtlas	NK cells, NK.b2m-.Sp, NK1.1+ TCRb-, Spleen, avg-3	KLRC2 KLRC3 KLRD1	4.06e-04	73	42	3	GSM538291_100
CoexpressionAtlas	NK cells, NK.DAP12-.Sp, NK1.1+ CD3-, Spleen, avg-3	KLRC2 KLRC3 KLRD1	4.23e-04	74	42	3	GSM538297_100
CoexpressionAtlas	NK cells, NK.49H-.Sp, NK1.1+, Spleen, avg-3	KLRC2 KLRC3 KLRD1	4.23e-04	74	42	3	GSM605817_100
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d15.VSVOva, CD8+ CD45.1+, Spleen, avg-2	KLRC2 KLRC3 KLRD1	4.40e-04	75	42	3	GSM538385_100
CoexpressionAtlas	NK cells, NK.H+.MCMV7.Sp, NK1.1+ TCRb- Ly49H+, Spleen, avg-3	KLRC2 KLRC3 KLRD1	4.40e-04	75	42	3	GSM538303_100
CoexpressionAtlas	NK cells, NK.H+.MCMV1.Sp, NK1.1+ TCRb- Ly49H+, Spleen, avg-3	KLRC2 KLRC3 KLRD1	4.40e-04	75	42	3	GSM538300_100
CoexpressionAtlas	alpha beta T cells, T.8Mem.Sp.OT1.d45.VSVOva, CD8+ CD45.1+, Spleen, avg-3	KLRC2 KLRC3 KLRD1	4.58e-04	76	42	3	GSM538403_100
CoexpressionAtlas	gamma delta T cells, Tgd.vg2-.act.Sp, TCRd+ Vg2- CD44+, Spleen, avg-3	KLRC2 KLRC3 KLRD1	4.58e-04	76	42	3	GSM476681_100
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d8.VSVOva, CD8+ CD45.1+, Spleen, avg-3	KLRC2 KLRC3 KLRD1	4.75e-04	77	42	3	GSM538392_100
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d8.LisOva, CD8+ CD45.1+, Spleen, avg-3	KLRC2 KLRC3 KLRD1	4.75e-04	77	42	3	GSM605901_100
CoexpressionAtlas	alpha beta T cells, T.8Mem.Sp.OT1.d106.VSVOva, CD8+ CD45.1+, Spleen, avg-2	KLRC2 KLRC3 KLRD1	4.75e-04	77	42	3	GSM538401_100
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d15.LisOva, CD8+ CD45.1+, Spleen, avg-3	KLRC2 KLRC3 KLRD1	4.75e-04	77	42	3	GSM605894_100
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d10.LisOva, CD8+ CD45.1+, Spleen, avg-3	KLRC2 KLRC3 KLRD1	4.94e-04	78	42	3	GSM605891_100
CoexpressionAtlas	alpha beta T cells, T.8Mem.Sp.OT1.d45.LisOva, CD8+ CD45.1+, Spleen, avg-2	KLRC2 KLRC3 KLRD1	4.94e-04	78	42	3	GSM605907_100
CoexpressionAtlas	alpha beta T cells, NKT.4-.Lv, CD45 TCRb aGalCer-loaded CD1d tet, Liver, avg-4	KLRC2 KLRC3 KLRD1	4.94e-04	78	42	3	GSM538325_100
CoexpressionAtlas	alpha beta T cells, NKT.44+NK1.1+.Th, aGC CD1d tet CD3e CD44 NK1.1, Thymus, avg-3	KLRC2 KLRC3 KLRD1	4.94e-04	78	42	3	GSM538332_100
CoexpressionAtlas	DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#2_top-relative-expression-ranked_1000	DLL1 LUC7L3 PRIMPOL	4.94e-04	78	42	3	gudmap_developingKidney_e15.5_Proximal Tubules_1000_k2
CoexpressionAtlas	alpha beta T cells, NKT.4-.Sp, TCRbeta+ aGalCer tet+ CD4-, Spleen, avg-3	KLRC2 KLRC3 KLRD1	4.94e-04	78	42	3	GSM538329_100
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPT LIM2 RNF17 KLRC2 KLRC3 KLRD1	1.34e-08	160	45	6	8590281165eab6514a9f6a022b900d4c222c1044
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	LIM2 KLRC2 KLRC3 KLRD1	2.47e-07	53	45	4	2147787ed3de18b49f51a8518984c7b6ba9a8cef
ToppCell	URO-Lymphocyte-T_NK-NK_CD56bright\|URO / Disease, Lineage and Cell Type	DLL1 ANGPTL7 KLRC2 KLRC3 KLRD1	3.82e-07	147	45	5	a6ca90e8dc37a016572ff68f34ab227b020eef70
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FAT4 DLL1 KLRC2 KLRC3 KLRD1	6.19e-07	162	45	5	9b1c07f0af657095379380c39d763cab0ad73e74
ToppCell	COVID-19_Moderate-NK_CD56bright\|COVID-19_Moderate / disease group, cell group and cell class	FAT4 DLL1 KLRC2 KLRC3 KLRD1	8.56e-07	173	45	5	a07dcb1e555caaa2235aec219334fcbf2d07f10c
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	LIM2 EML4 KLRC2 KLRC3 KLRD1	1.04e-06	180	45	5	ddbab26b05f057bd78b78773381cd447bd2e2726
ToppCell	10x5'v1-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	LIM2 DLL1 KLRC2 KLRC3 KLRD1	1.19e-06	185	45	5	593eceb3dfcc662c892a840ba29ab687c6886c01
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	LIM2 EML4 KLRC2 KLRC3 KLRD1	1.32e-06	189	45	5	723c57f278919e8251d56b3d19411f9088319450
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK-T_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	LIM2 EML4 KLRC2 KLRC3 KLRD1	1.32e-06	189	45	5	960374f5fb278659500a7c948c3068a95dd62eb0
ToppCell	BAL-Mild-Lymphocyte-T/NK-NK_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LIM2 FAT4 KLRC2 KLRC3 KLRD1	1.54e-06	195	45	5	4eb13aa9fc496caca6e0a4fb80d11a60cf2511b0
ToppCell	BAL-Mild-Lymphocyte-T/NK-NK_cell-NK-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LIM2 FAT4 KLRC2 KLRC3 KLRD1	1.54e-06	195	45	5	234666fb7a1fd7e33bb7e54fd4004649ce22de70
ToppCell	BAL-Mild-Lymphocyte-T/NK-NK_cell-NK\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LIM2 FAT4 KLRC2 KLRC3 KLRD1	1.54e-06	195	45	5	90c77b7f245b1bf80ba293583f8fe343b14c7f67
ToppCell	BAL-Mild-Lymphocyte-T/NK-NK_cell-NK\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	LIM2 FAT4 KLRC2 KLRC3 KLRD1	1.54e-06	195	45	5	f0fb039f3d2e36acb258afb8b6d2fed20c395c36
ToppCell	BAL-Mild-Lymphocyte-T/NK-NK_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	LIM2 FAT4 KLRC2 KLRC3 KLRD1	1.54e-06	195	45	5	c7743d8c57584d29cca69c6405f1df6718174582
ToppCell	BAL-Mild-Lymphocyte-T/NK-NK_cell-NK-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LIM2 FAT4 KLRC2 KLRC3 KLRD1	1.54e-06	195	45	5	89d832d1715f2720caa8cdd1e7ef847d79642556
ToppCell	Control-Lymphocyte-T_NK-NK_CD56bright\|Control / Disease, Lineage and Cell Type	DLL1 KLRC2 KLRC3 KLRD1 USP47	1.58e-06	196	45	5	c0ebef067aa333c7a18c697031b0417b3335b75c
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD16\|lymph-node_spleen / Manually curated celltypes from each tissue	LIM2 KLRC2 KLRC3 KLRD1 SMAD7	1.58e-06	196	45	5	f7e5a7fad4547e8ab9ab8b140239281832fb4260
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	LIM2 FAT4 KLRC2 KLRC3 KLRD1	1.62e-06	197	45	5	bc37b8919f98dc18c2200834405f06823d965d78
ToppCell	Mild-Lymphoid-NK-NK\|Mild / Condition, Lineage, Cell class and cell subclass	LIM2 FAT4 KLRC2 KLRC3 KLRD1	1.66e-06	198	45	5	4999cc14642df704819be55594a07eab9c6527aa
ToppCell	Mild-Lymphoid-NK\|Mild / Condition, Lineage, Cell class and cell subclass	LIM2 FAT4 KLRC2 KLRC3 KLRD1	1.70e-06	199	45	5	ae8b16e5463c3c41807fef187ee9f501df07e452
ToppCell	Smart-seq2-blood_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LANCL1 LIM2 IRF6 KLRD1	1.18e-05	139	45	4	a542ef99ba57f364ea9707b3119e11f5a240034c
ToppCell	facs-Spleen-nan-24m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VEGFC KLRC2 KLRC3 KLRD1	1.76e-05	154	45	4	bd283c2367afb99294e7576a0c0167eb7c69ad6b
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLL1 KLRC2 KLRC3 KLRD1	1.81e-05	155	45	4	7a16df1a40c7255c24dfb9a921b62871554c7b6d
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLL1 KLRC2 KLRC3 KLRD1	1.81e-05	155	45	4	f51a12556ca0a3416a6cf0687f908fb4e752fb2f
ToppCell	Leuk-UTI-Lymphocyte-T_NK-gdT\|Leuk-UTI / Disease, Lineage and Cell Type	TDRD6 KLRC2 KLRC3 KLRD1	1.95e-05	158	45	4	c4b0af25608cee3d0d2b0193f5ff45d9dc87078b
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIM2 KLRC2 KLRC3 KLRD1	2.00e-05	159	45	4	d2de9391b00b6c47f5fe28a1bad6da2097107ee0
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIM2 KLRC2 KLRC3 KLRD1	2.00e-05	159	45	4	da6b7f8039adc19839d6c090a0b3d68fb6445a79
ToppCell	facs-Lung-nan-3m-Lymphocytic-Natural_Killer\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RNF17 KLRC2 KLRC3 KLRD1	2.10e-05	161	45	4	ae1cee34361dde9964581cca99a29578c3b3bd99
ToppCell	facs-Lung-nan-3m-Lymphocytic-NK_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RNF17 KLRC2 KLRC3 KLRD1	2.10e-05	161	45	4	33de3e8b3238fcfc66dfbf89a913a07d464d6c35
ToppCell	droplet-Spleen-nan-3m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VEGFC KLRC2 KLRC3 KLRD1	2.20e-05	163	45	4	2e1c1193c04620cc187b1567dfba025beef1e4e1
ToppCell	facs-Spleen-nan-3m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VEGFC KLRC2 KLRC3 KLRD1	2.26e-05	164	45	4	a187bd5beca017ef657ef07c006e7f94ea3b911b
ToppCell	Healthy-NK_CD56bright\|Healthy / disease group, cell group and cell class	DLL1 KLRC2 KLRC3 KLRD1	2.26e-05	164	45	4	ed193211965accba60a256d3e6c159f0fc911d8b
ToppCell	droplet-Spleen-nan-24m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLL1 KLRC2 KLRC3 KLRD1	2.26e-05	164	45	4	7a51365bad2910c130bd952805f7a1bef51be481
ToppCell	droplet-Spleen-SPLEEN-30m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DLL1 KLRC2 KLRC3 KLRD1	2.31e-05	165	45	4	e24621c8d4dbafb407033d832fe9337f13feae34
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VEGFC DLL1 KLRC2 KLRD1	2.42e-05	167	45	4	aef22535a76e93472bcedacbb2c6991f3c9c8cd5
ToppCell	Healthy-NK_CD56bright\|World / disease group, cell group and cell class	DLL1 KLRC2 KLRC3 KLRD1	2.42e-05	167	45	4	ab7a570a75ee2018b9fe886cdec79cda27f1563f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	LIM2 KLRC2 KLRC3 KLRD1	2.48e-05	168	45	4	240ea32b64d86f9216785010d6b237d9adf052c9
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	LIM2 KLRC2 KLRC3 KLRD1	2.48e-05	168	45	4	b4bb03efb601a61465260f93896c56861c588bef
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-NK_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VEGFC LIM2 KLRC2 KLRD1	2.54e-05	169	45	4	a24d12199b1a6d9cb243b3a68f4109d3a30b2dcb
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-CD45____NK_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VEGFC LIM2 KLRC2 KLRD1	2.54e-05	169	45	4	573f85075d83a4baba41c3e24dc4d9831823a5e5
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	LIM2 KLRC2 KLRC3 KLRD1	2.54e-05	169	45	4	e7470a5b060881b2a8ce2ab04b0788396aa13889
ToppCell	COVID-19_Moderate-NK_CD56bright\|World / disease group, cell group and cell class	DLL1 KLRC2 KLRC3 KLRD1	2.60e-05	170	45	4	caa6a534c1e9639caced9a51680f5c905f061bcc
ToppCell	droplet-Thymus-nan-18m-Lymphocytic-DN4\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 KLRC2 KLRD1 SMAD7	2.66e-05	171	45	4	f08402d0f42822c35673522043b652f8fb68d2f6
ToppCell	NS-critical-LOC-Lymphoid-NK\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LIM2 KLRC2 KLRC3 KLRD1	2.66e-05	171	45	4	adda76991d9b150bb8ccf3989b7cbbf41843cf0b
ToppCell	facs-Marrow-T-cells\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPT KLRC2 KLRC3 KLRD1	2.78e-05	173	45	4	806f94f5c3ac836ddffc389d3c2cd7e4da7a608d
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_T_(gd)\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DLL1 KLRC2 KLRC3 KLRD1	2.78e-05	173	45	4	62f2f42f54c9c6941bf888956be40230f92c883e
ToppCell	Int-URO-Lymphocyte-T_NK-NK_CD56bright\|Int-URO / Disease, Lineage and Cell Type	DLL1 KLRC2 KLRC3 KLRD1	2.84e-05	174	45	4	93c7acd5941a5f235ec4c57461f78ee2871e7336
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANGPTL7 KLRC2 KLRC3 KLRD1	2.91e-05	175	45	4	8fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4
ToppCell	wk_15-18-Hematologic_Lymphocytic-NK-Activated_NK\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	LIM2 KLRC2 KLRC3 KLRD1	2.97e-05	176	45	4	6802ed40eb0f91674d4f0120a3d4888c8a2e9612
ToppCell	wk_20-22-Hematologic_Lymphocytic-NK-Activated_NK\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	LIM2 KLRC2 KLRC3 KLRD1	3.11e-05	178	45	4	5b19dbf9dc8e41e6a16a2abbb798d49ee8d8653f
ToppCell	droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 EML4 KLRD1 SMAD7	3.11e-05	178	45	4	8aef208b6351143562c87715bb11628880abce94
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	LIM2 KLRC2 KLRC3 KLRD1	3.25e-05	180	45	4	1c8398342d3fa4d5ca9a8a63626cc497c5291446
ToppCell	mild_COVID-19-NK_CD56bright\|mild_COVID-19 / disease group, cell group and cell class (v2)	DLL1 KLRC2 KLRC3 KLRD1	3.25e-05	180	45	4	d8b418edd807a51c0b5f4018b8b478dcc65892a7
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK-T_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	LIM2 KLRC2 KLRC3 KLRD1	3.25e-05	180	45	4	0a98d21fec67a890e75ebf0e2d23adddd77da214
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 EML4 KLRD1 SMAD7	3.39e-05	182	45	4	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 EML4 KLRD1 SMAD7	3.39e-05	182	45	4	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	normal-na-Lymphocytic_T-CytoT_GZMK+-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	EML4 KLRC2 KLRC3 KLRD1	3.46e-05	183	45	4	79defd22b3194dad16db55b9bdd220c09c1e6b90
ToppCell	COVID-19_Mild-CD8+_T_activated\|COVID-19_Mild / Disease condition and Cell class	RNF17 KLRC2 KLRC3 KLRD1	3.46e-05	183	45	4	ac1ca5d613fa9888ccc63cb0bdce95aefd02cdd7
ToppCell	3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|bone_marrow / Manually curated celltypes from each tissue	USP9Y KLRC2 KLRC3 KLRD1	3.46e-05	183	45	4	37db007cc65005bffc18a5fda7f454a57c9fb0a9
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VEGFC DLL1 ARMCX1 SMAD7	3.46e-05	183	45	4	fc9a7ba148c22d0c8a46f6bc56c772929ac496f7
ToppCell	3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo\|bone_marrow / Manually curated celltypes from each tissue	USP9Y KLRC2 KLRC3 KLRD1	3.46e-05	183	45	4	2fb78622adc170dd3301e251418337523de50faf
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	FAT4 ZNF518B TMEM215 MYCBP2	3.54e-05	184	45	4	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	COVID-19_Mild-Lymphoid_T/NK-NK_CD56bright\|COVID-19_Mild / Disease group, lineage and cell class	DLL1 KLRC2 KLRC3 KLRD1	3.54e-05	184	45	4	f67308228bb6a5d624279fbb04db25a2f4087c9b
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DLL1 KLRC2 KLRC3 KLRD1	3.61e-05	185	45	4	3a046c948524e5d0e986cd645e318d6930d7e0ee
ToppCell	normal-na-Lymphocytic_T-CytoT_GZMH+-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	ANGPTL7 KLRC2 KLRC3 KLRD1	3.61e-05	185	45	4	097d628f92e13250c15b550f2fd1f4225fc07558
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DLL1 KLRC2 KLRC3 KLRD1	3.61e-05	185	45	4	71d1a771026d9fa3528d46ac3d11353e396f2d87
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DLL1 KLRC2 KLRC3 KLRD1	3.61e-05	185	45	4	df5d2309d19ac8d5e429afa785d0a480e75a8f9e
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DLL1 KLRC2 KLRC3 KLRD1	3.61e-05	185	45	4	37b48218dd523049b57b13eb9cdb34e106cf91ea
ToppCell	Mild-NK\|World / Disease group and Cell class	VEGFC DLL1 KLRC3 KLRD1	3.61e-05	185	45	4	0565b7c464e1a09e596f5a0b363d2dc9b55c3c50
ToppCell	IIH-NK\|IIH / Condition, Cell_class and T cell subcluster	LIM2 KLRC2 KLRC3 KLRD1	3.69e-05	186	45	4	cab1249b849013cf0334f25ee8d840f0521f4eb8
ToppCell	IIH-NK-\|IIH / Condition, Cell_class and T cell subcluster	LIM2 KLRC2 KLRC3 KLRD1	3.69e-05	186	45	4	2c90b45c8ccfd86bbf6840dba7f0d7f08b5ea914
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-NK_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRDM13 KLRC2 KLRC3 KLRD1	3.69e-05	186	45	4	e37e317e9770e35cb41137f51868d8b20ecd21d8
ToppCell	COVID-NK-\|COVID / Condition, Cell_class and T cell subcluster	DLL1 KLRC2 KLRC3 KLRD1	3.85e-05	188	45	4	fabdd68a9734d35e75e1f4a4bfd5c531cfc099f1
ToppCell	COVID-19_Mild-Lymphoid_T/NK-CD8+_T_activated\|COVID-19_Mild / Disease group, lineage and cell class	RNF17 KLRC2 KLRC3 KLRD1	3.85e-05	188	45	4	1aecae0d94905bfbd414adf1450035e5b863abe7
ToppCell	COVID-NK\|COVID / Condition, Cell_class and T cell subcluster	DLL1 KLRC2 KLRC3 KLRD1	3.85e-05	188	45	4	0beaa671611110a11e46156f54f5202cc24967a4
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	LIM2 KLRC2 KLRC3 KLRD1	3.85e-05	188	45	4	0a2be6eac6fde669fbc58fd1b2e93e4acf17ddde
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	RNF17 KLRC2 KLRC3 KLRD1	3.93e-05	189	45	4	eb5b107dbc50e538dc27ba2867b196a23a8054bf
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-\|bone_marrow / Manually curated celltypes from each tissue	DLL1 KLRC2 KLRC3 KLRD1	3.93e-05	189	45	4	6e402fb3fc31e4cb541e3cd140d7a86c1083dbf5
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RNF17 KLRC2 KLRC3 KLRD1	3.93e-05	189	45	4	c6760ea8ecca6abdd9eb067f3b3f4eea9420b852
ToppCell	COVID-19_Moderate-NK_activated\|COVID-19_Moderate / disease group, cell group and cell class	LIM2 KLRC2 KLRC3 KLRD1	3.93e-05	189	45	4	8f9f1e71857bed6d59c4b087b6a6970f30fd86be
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RNF17 KLRC2 KLRC3 KLRD1	3.93e-05	189	45	4	af5f92dc3b3bc6acacd633981b8ef7f0c593c92e
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RNF17 KLRC2 KLRC3 KLRD1	3.93e-05	189	45	4	04bdcf05b8c72c13e7d35d1c7444f50374d41203
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	KLRC2 KLRC3 KLRD1 SMAD7	4.09e-05	191	45	4	04faa7d2237e45418611153294eb6f7bb690cbde
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VEGFC DLL1 ARMCX1 SMAD7	4.09e-05	191	45	4	27f23c2254b610abac1a88d0fecff305addde9da
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	LIM2 KLRC2 KLRC3 KLRD1	4.18e-05	192	45	4	e48bbcb97c113f323ad4db96bd10d593b9206923
ToppCell	MS-NK\|MS / Condition, Cell_class and T cell subcluster	FAT4 DLL1 KLRC2 KLRD1	4.18e-05	192	45	4	f44f5dd30db169fdd16c9d706d17ad44907a17af
ToppCell	MS-NK-\|MS / Condition, Cell_class and T cell subcluster	FAT4 DLL1 KLRC2 KLRD1	4.18e-05	192	45	4	f97f5f8226f5c65ca93072ef35d753231bee2490
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	LIM2 KLRC2 KLRC3 KLRD1	4.26e-05	193	45	4	54604c2c5dce2ff6f3ec7ca82b595b09b8cdafe8
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KLRC2 KLRC3 KLRD1 SMAD7	4.26e-05	193	45	4	a594f89a18273797506287d9e22f72abe53e4920
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	EML4 KLRC2 KLRC3 KLRD1	4.26e-05	193	45	4	46f94a1062b098205e8ce3ed380c0202a4d97678
ToppCell	Mild_COVID-19-T/NK-NK\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	LIM2 KLRC2 KLRC3 KLRD1	4.26e-05	193	45	4	9c455d9d845fa230e9a61d9a5f9d6a2ccf5d7350
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-NK_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LIM2 KLRC2 KLRC3 KLRD1	4.26e-05	193	45	4	044fba87c4d10f4943a9f57315920280a4d097e7
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|bone_marrow / Manually curated celltypes from each tissue	EML4 KLRC2 KLRC3 KLRD1	4.26e-05	193	45	4	1788f865fc9f9a235dbfaf363ed1985fdc715394
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	LIM2 KLRC2 KLRC3 KLRD1	4.35e-05	194	45	4	5a859885c0f9b8554b0d203e371c70928ad4418f
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo\|bone_marrow / Manually curated celltypes from each tissue	EML4 KLRC2 KLRC3 KLRD1	4.35e-05	194	45	4	afbf3cecffa2c5e830ebca5db950528cc78fd269
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK-T_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	LIM2 KLRC2 KLRC3 KLRD1	4.35e-05	194	45	4	7d35ac70ba966eb1fee4197f7de6d6116326a442
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DLL1 KLRC2 KLRC3 KLRD1	4.35e-05	194	45	4	afa8d29924719af3bc5f48f22cf66d5e8f9e3e37
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Trm_gut_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	EML4 KLRC2 KLRC3 KLRD1	4.35e-05	194	45	4	e9db509ff75f8605365841276fac6cec66ae27c7
ToppCell	ICU-NoSEP-Lymphocyte-T_NK-NK\|ICU-NoSEP / Disease, Lineage and Cell Type	LIM2 KLRC2 KLRC3 KLRD1	4.35e-05	194	45	4	090edfc884655e5ab38b027c6e1a5aa809ebb19d
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DLL1 KLRC2 KLRC3 KLRD1	4.35e-05	194	45	4	aee60da2e7aed161cdd4abbfad6864665aaa8f5c
Disease	melanoma	VEGFC FAT4 HDAC6 TRRAP	4.24e-04	248	42	4	C0025202
Disease	Hepatitis	DPT FAT4	4.49e-04	22	42	2	HP_0012115
Disease	electrocardiography	VEGFC DPT MYCBP2 KCNQ4 SMAD7	9.02e-04	530	42	5	EFO_0004327
Disease	Brain Tumor, Primary	DLL1 EML4	1.02e-03	33	42	2	C0750974
Disease	Primary malignant neoplasm of brain	DLL1 EML4	1.02e-03	33	42	2	C0750979
Disease	Recurrent Brain Neoplasm	DLL1 EML4	1.02e-03	33	42	2	C0750977
Disease	Neoplasms, Intracranial	DLL1 EML4	1.02e-03	33	42	2	C1527390
Disease	Benign neoplasm of brain, unspecified	DLL1 EML4	1.02e-03	33	42	2	C0496899
Disease	Malignant neoplasm of brain	DLL1 EML4	1.35e-03	38	42	2	C0153633
Disease	Brain Neoplasms	DLL1 EML4	1.42e-03	39	42	2	C0006118
Disease	immunoglobulin isotype switching measurement	KLRC2 KLRC3	1.80e-03	44	42	2	EFO_0010128

Protein segments in the cluster

Peptide	Gene	Start	Entry
YCYECEGLLWGIARQ	UNC13A	566	Q9UPW8
EWVYNTFCIYKRCRH	C4BPA	101	P04003
CILCRLCVYSNNIYW	EDDM3A	16	Q14507
SNIYRYDERKEVWCL	CCIN	391	Q13939
GDLLCINQWYAYRCV	FAT4	4411	Q6V0I7
ESVLDREWQFYCCRY	DPT	121	Q07507
RWYQRCCETCRDFYA	ADAMTS19	1186	Q8TE59
CLDKCAQLRKGGYWY	ANGPTL7	281	O43827
VRRLLGYWICCRKYD	OR2AK2	316	Q8NG84
GLWRYCLGNKCYLQT	LIM2	41	P55344
YRACKFAEWCLEYGE	LANCL1	346	O43813
EYIVRVWSAGCCCRY	KCNQ4	146	P56696
FGLCYDYKIRVNCCW	MUC2	1376	Q02817
NVRWDHESVCKYYLC	LUC7L3	26	O95232
ERYCPRRNEWGYACS	KLHL26	431	Q53HC5
LGCWFHCRYNYAKQR	COX20	71	Q5RI15
RVGWQGRYCDECIRY	DLL1	246	O00548
GRCVTCIYYLNKDWD	EGLN1	321	Q9GZT9
LEWAYGYRGKDCRAN	EML4	261	Q9HC35
ENWVCLSCYQVYCGR	HDAC6	1141	Q9UBN7
EKGEERYICWYCWRT	PRDM13	131	Q9H4Q3
YDICKYRWCENIGRA	PRIMPOL	411	Q96LW4
IYAIRLCQCKVYWSG	IRF6	311	O14896
GRCIRDEECYYHWGR	REXO1	986	Q8N1G1
CKDCYLVKRRGRWYV	MRPL36	76	Q9P0J6
DLCCVKWKENGYYRA	TDRD6	541	O60522
NSCYYIGKERRTWEE	KLRC2	126	P26717
RCGRKLAKDGEYYWC	GMCL2	396	Q8NEA9
WYLVCDRCREKYLRE	MYCBP2	3296	O75592
NSCYYIGKERRTWEE	KLRC3	126	Q07444
VDYRAKLWACNFCYQ	SEC23A	76	Q15436
CYCVYRLAWGRDENE	ARMCX1	21	Q9P291
CLAEYDDGLWYRAKI	RNF17	1486	Q9BXT8
YWEEKTRVGRLYCVQ	SMAD7	266	O15105
YSEEVCRCVPSYWKR	VEGFC	401	P49767
DRYCCYINQIQGRWD	TMEM215	216	Q68D42
RYQRWLQYKFFCLLC	RLF	546	Q13129
KDYVRCLECGYEGWR	USP47	306	Q96K76
YLCDREACFKWYSKL	USP9Y	691	O00507
YGFICYNIWCNVRGK	AVPR1A	236	P37288
IVERLCACCYEQAWY	TRRAP	1141	Q9Y4A5
FWNYLERCRYCNVLC	TNFRSF6B	81	O95407
FKCWFCGRLYEDQEE	ZNF518B	1036	Q9C0D4
CQEKWVGYRCNCYFI	KLRD1	61	Q13241
CNAYNISDVCYKRDW	NEB	1286	P20929